Previous Article | Next Article 
Infection and Immunity, January 2000, p. 87-92, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Resistance of Transgenic Mice Expressing Human
Group II Phospholipase A2 to Escherichia coli
Infection
V. Jukka O.
Laine,1,*
David S.
Grass,2 and
Timo J.
Nevalainen1
Department of Pathology, University of Turku,
20520 Turku, Finland,1 and Chrysalis
DNX Transgenics, Princeton, New Jersey 085402
Received 10 June 1999/Returned for modification 11 August
1999/Accepted 20 October 1999
Group II phospholipase A2 (PLA2) is a newly recognized
antibacterial acute-phase protein. Recently we observed that transgenic mice expressing group II PLA2 (PLA2+ mice) were able to
resist experimental Staphylococcus aureus infection by killing the bacteria, as indicated by improved survival and by the small numbers of live bacteria in their tissues (V. J. O. Laine, D. S. Grass, and T. J. Nevalainen, J. Immunol. 162:7402-7408, 1999). To establish the role of group II PLA2
in Escherichia coli infection, the host responses of
PLA2+ mice and their PLA2-deficient C57BL/6J littermates
(PLA2
mice) were studied after intraperitoneal
administration of E. coli. The levels of group II PLA2 in
sera of PLA2+ mice increased after the administration of
E. coli, and the concentration of group II PLA2 correlated
significantly with the catalytic activity of PLA2 in serum.
PLA2+ mice showed lower rates of mortality and less
bacterial growth in peritoneal lavage fluid, blood, and spleen and
liver tissues than PLA2
mice. Unlike the observations
with staphylococcal infection, serum and peritoneal lavage fluid did
not inhibit the growth of E. coli in vitro. The results
indicate that expression of the group II PLA2 transgene
improves the host defense of mice against E. coli infection.
*
Corresponding author. Mailing address: Department of
Pathology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland. Phone: (358) 2-261 2670. Fax: (358) 2-333 7459. E-mail: vellai{at}utu.fi.
Infection and Immunity, January 2000, p. 87-92, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hurley, B. P., McCormick, B. A.
(2008). Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation. Infect. Immun.
76: 2259-2272
[Full Text]
-
Koprivnjak, T., Weidenmaier, C., Peschel, A., Weiss, J. P.
(2008). Wall Teichoic Acid Deficiency in Staphylococcus aureus Confers Selective Resistance to Mammalian Group IIA Phospholipase A2 and Human {beta}-Defensin 3. Infect. Immun.
76: 2169-2176
[Abstract]
[Full Text]
-
Kim, J.-O., Chakrabarti, B. K., Guha-Niyogi, A., Louder, M. K., Mascola, J. R., Ganesh, L., Nabel, G. J.
(2007). Lysis of Human Immunodeficiency Virus Type 1 by a Specific Secreted Human Phospholipase A2. J. Virol.
81: 1444-1450
[Abstract]
[Full Text]
-
Kirschnek, S., Gulbins, E.
(2006). Phospholipase A2 Functions in Pseudomonas aeruginosa- Induced Apoptosis. Infect. Immun.
74: 850-860
[Abstract]
[Full Text]
-
Wootton, P. T.E., Drenos, F., Cooper, J. A., Thompson, S. R., Stephens, J. W., Hurt-Camejo, E., Wiklund, O., Humphries, S. E., Talmud, P. J.
(2006). Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study. Hum Mol Genet
15: 355-361
[Abstract]
[Full Text]
-
Piris-Gimenez, A., Paya, M., Lambeau, G., Chignard, M., Mock, M., Touqui, L., Goossens, P. L.
(2005). In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax. J. Immunol.
175: 6786-6791
[Abstract]
[Full Text]
-
Femling, J. K., Nauseef, W. M., Weiss, J. P.
(2005). Synergy between Extracellular Group IIA Phospholipase A2 and Phagocyte NADPH Oxidase in Digestion of Phospholipids of Staphylococcus aureus Ingested by Human Neutrophils. J. Immunol.
175: 4653-4661
[Abstract]
[Full Text]
-
Tan, X.-X., Actor, J. K., Chen, Y.
(2005). Peptide Nucleic Acid Antisense Oligomer as a Therapeutic Strategy against Bacterial Infection: Proof of Principle Using Mouse Intraperitoneal Infection. Antimicrob. Agents Chemother.
49: 3203-3207
[Abstract]
[Full Text]
-
Dubouix, A., Campanac, C., Fauvel, J., Simon, M.-F., Salles, J.-P., Roques, C., Chap, H., Marty, N.
(2003). Bactericidal properties of group IIa secreted phospholipase A2 against Pseudomonas aeruginosa clinical isolates. J Med Microbiol
52: 1039-1045
[Abstract]
[Full Text]
-
Tietge, U. J. F., Maugeais, C., Cain, W., Rader, D. J.
(2003). Acute inflammation increases selective uptake of HDL cholesteryl esters into adrenals of mice overexpressing human sPLA2. Am. J. Physiol. Endocrinol. Metab.
285: E403-E411
[Abstract]
[Full Text]
-
Park, D.-W., Kim, J.-R., Kim, S.-Y., Sonn, J.-K., Bang, O.-S., Kang, S.-S., Kim, J.-H., Baek, S.-H.
(2003). Akt as a Mediator of Secretory Phospholipase A2 Receptor-Involved Inducible Nitric Oxide Synthase Expression. J. Immunol.
170: 2093-2099
[Abstract]
[Full Text]
-
Koprivnjak, T., Peschel, A., Gelb, M. H., Liang, N. S., Weiss, J. P.
(2002). Role of Charge Properties of Bacterial Envelope in Bactericidal Action of Human Group IIA Phospholipase A2 against Staphylococcus aureus. J. Biol. Chem.
277: 47636-47644
[Abstract]
[Full Text]
-
Koduri, R. S., Gronroos, J. O., Laine, V. J. O., Le Calvez, C., Lambeau, G., Nevalainen, T. J., Gelb, M. H.
(2002). Bactericidal Properties of Human and Murine Groups I, II, V, X, and XII Secreted Phospholipases A2. J. Biol. Chem.
277: 5849-5857
[Abstract]
[Full Text]
-
Cummings, B. S., McHowat, J., Schnellmann, R. G.
(2000). Phospholipase A2s in Cell Injury and Death. J. Pharmacol. Exp. Ther.
294: 793-799
[Abstract]
[Full Text]
-
Murakami, M., Koduri, R. S., Enomoto, A., Shimbara, S., Seki, M., Yoshihara, K., Singer, A., Valentin, E., Ghomashchi, F., Lambeau, G., Gelb, M. H., Kudo, I.
(2001). Distinct Arachidonate-releasing Functions of Mammalian Secreted Phospholipase A2s in Human Embryonic Kidney 293 and Rat Mastocytoma RBL-2H3 Cells through Heparan Sulfate Shuttling and External Plasma Membrane Mechanisms. J. Biol. Chem.
276: 10083-10096
[Abstract]
[Full Text]